Nicofibrate hydrochloride is a bioactive compound which may cause a significant reduction in plasma cholesterol and triglycerides and bring lipoprotein levels to normal. Nicofibrate HCl may also lead to a significant drop in plasma prothrombinic activity. References: Gragnoli G, Postorino G, Tanganelli I, Brandi L. [Therapeutic effects of nicofibrate on diabetic hyperlipemia]. Minerva Med. 1977 Apr 21;68(19):1281-92. Italian. PubMed PMID: 323747.

纯度：≥98%

CAS：17413-51-3